A US clinical trial network is needed for the next pandemic
Nat Med
.
2022 Jul;28(7):1330-1331.
doi: 10.1038/s41591-022-01831-1.
Authors
Rieko Yajima
1
2
,
Alexander F More
3
4
,
Cynthia Garvan
5
,
Corina Harper
6
,
Kevin V Grimes
7
8
Affiliations
1
SPARK Program in Translational Research, Stanford University School of Medicine, Stanford, CA, USA.
2
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA.
3
Department of Public Health, Long Island University, New York, NY, USA.
4
Initiative for the Science of the Human Past, Harvard University, Cambridge, MA, USA.
5
Department of Anesthesiology, University of Florida, Gainesville, FL, USA.
6
Alexion AstraZeneca Rare Disease, Boston, MA, USA.
7
SPARK Program in Translational Research, Stanford University School of Medicine, Stanford, CA, USA. kgrimes@stanford.edu.
8
Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, USA. kgrimes@stanford.edu.
PMID:
35641823
DOI:
10.1038/s41591-022-01831-1
No abstract available
Publication types
Letter
MeSH terms
Humans
Influenza, Human* / epidemiology
Pandemics* / prevention & control